These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14532675)

  • 21. Ethyl 2-methoxy-6-[(triphenylphosphoranylidene)amino]nicotinate and ethyl 2-methylsulfanyl-6-[(triphenylphosphoranylidene)amino]nicotinate.
    Cobo J; Glidewell C; Low JN; Orozco F
    Acta Crystallogr C; 2008 Apr; 64(Pt 4):o233-6. PubMed ID: 18391397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-ray structure analysis of a solid solution of milbemycins A3 and A4.
    Bizdena E; Belyakov S; Jure M; Grinsteine I; Kumpiņš V; Turks M
    Nat Prod Res; 2013 Oct; 27(20):1936-9. PubMed ID: 23631374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolated pulmonary hypertension and pergolide].
    Evrard F; Dupuis M; Muller T; Jacquerye P
    Rev Neurol (Paris); 2008 Mar; 164(3):278-9. PubMed ID: 18405780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General pharmacology of pergolide in animals. 1st communication: cardiovascular, respiratory and autonomic nervous system studies.
    Williams P; Colbert W; Turk J; Owen N
    Arzneimittelforschung; 1992 May; 42(5):599-607. PubMed ID: 1530670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new polymorph of N-(6-methylpyridin-2-yl)mesitylenesulfonamide.
    Pan F; Englert U
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1217-20. PubMed ID: 24192161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rounded atelectasis and respiratory compromise secondary to pergolide use.
    Bloom CI; Wilson GE
    Respirology; 2009 Aug; 14(6):906-7. PubMed ID: 19659834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new polymorph and two pseudopolymorphs of pyrimethamine.
    Tutughamiarso M; Bolte M
    Acta Crystallogr C; 2011 Nov; 67(Pt 11):o428-34. PubMed ID: 22051957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three 2-(methysulfanyl)nicotinamides.
    Gomes LR; Low JN; Wardell JL; Pinheiro AC; de Mendonça TC; de Souza MV
    Acta Crystallogr C; 2013 Mar; 69(Pt 3):293-8. PubMed ID: 23459359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 30. Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease.
    Kleinberg DL; Lieberman A; Todd J; Greising J; Neophytides A; Kupersmith M
    J Clin Endocrinol Metab; 1980 Jul; 51(1):152-4. PubMed ID: 6769937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.
    Van Camp G; Flamez A; Cosyns B; Weytjens C; Muyldermans L; Van Zandijcke M; De Sutter J; Santens P; Decoodt P; Moerman C; Schoors D
    Lancet; 2004 Apr; 363(9416):1179-83. PubMed ID: 15081648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nine N-aryl-2-chloronicotinamides: supramolecular structures in one, two and three dimensions.
    Cuffini S; Glidewell C; Low JN; de Oliveira AG; de Souza MV; Vasconcelos TR; Wardell SM; Wardell JL
    Acta Crystallogr B; 2006 Aug; 62(Pt 4):651-65. PubMed ID: 16840815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclinic and orthorhombic polymorphs of 4,4',6,6'-tetrachloro-2,2'-(piperazine-1,4-diyldimethylene)diphenol.
    Kubono K; Yokoi K
    Acta Crystallogr C; 2007 Sep; 63(Pt 9):o535-7. PubMed ID: 17762126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
    Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J
    Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial.
    Pohanka M; Kanovský P; Bares M; Pulkrábek J; Rektor I
    Parkinsonism Relat Disord; 2005 Dec; 11(8):509-12. PubMed ID: 15994112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anhydrous 1:1 proton-transfer compounds of isonipecotamide with picric acid and 3,5-dinitrosalicylic acid: 4-carbamoylpiperidinium 2,4,6-trinitrophenolate and two polymorphs of 4-carbamoylpiperidinium 2-carboxy-4,6-dinitrophenolate.
    Smith G; Wermuth UD
    Acta Crystallogr C; 2010 Dec; 66(Pt 12):o609-13. PubMed ID: 21123895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optically active diaryl tetrahydroisoquinoline derivatives.
    Naicker T; Govender T; Kruger HG; Maguire GE
    Acta Crystallogr C; 2011 Mar; 67(Pt 3):o100-3. PubMed ID: 21368406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supramolecular sheets in (4H-chromeno[4,3-c]isoxazol-3-yl)methanol and its hydrated 8-methyl-substituted analogue at 100 K.
    Rajalakshmi P; Srinivasan N; Krishnakumar RV; Razak IA; Rosli MM
    Acta Crystallogr C; 2012 Nov; 68(Pt 11):o481-4. PubMed ID: 23124468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
    Corvol JC; Anzouan-Kacou JB; Fauveau E; Bonnet AM; Lebrun-Vignes B; Girault C; Agid Y; Lechat P; Isnard R; Lacomblez L
    Arch Neurol; 2007 Dec; 64(12):1721-6. PubMed ID: 18071034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.
    Zanettini R; Antonini A; Gatto G; Gentile R; Tesei S; Pezzoli G
    Cardiovasc Ther; 2011 Dec; 29(6):404-10. PubMed ID: 20553285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.